Skip to main content
Ortivus logo

Ortivus — Investor Relations & Filings

Ticker · ORTI ISIN · SE0000188930 LEI · 549300AVDV7UC14MTH79 ST Manufacturing
Filings indexed 511 across all filing types
Latest filing 2022-09-09 Regulatory Filings
Country SE Sweden
Listing ST ORTI

About Ortivus

https://www.ortivus.com/

Ortivus is a medical technology company that develops and supplies mobile solutions for prehospital and emergency medical care. The company's core product is MobiMed, an advanced electronic Patient Care Record (ePCR) system designed for paramedics and emergency medical services (EMS) providers. MobiMed facilitates real-time documentation and data sharing directly from the field. The platform integrates with a wide range of medical devices, such as patient monitors and defibrillators, as well as with hospital patient administration systems and national health registries. This ensures seamless information flow across the entire care pathway. Key functionalities include structured workflows, automated risk assessments, secure communication, and a web portal for real-time incident overviews. The system also supports telemedicine capabilities, including video consultations. By optimizing documentation and providing actionable insights, Ortivus solutions aim to improve patient safety, enhance care quality, and increase operational efficiency for healthcare organizations.

Recent filings

Filing Released Lang Actions
Region Gävleborg has decided to award Ortivus a contract on the delivery of semi-automatic defibrillators
Regulatory Filings Classification · 95% confidence The document announces a specific business event: Region Gävleborg awarding a contract to Ortivus for defibrillator delivery. This is a material, non-financial announcement related to business operations and contracts. It is not an Annual Report (10-K), Earnings Release (ER), or Interim Report (IR). It does not fit the definitions for Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP). Since it is a specific, material announcement that doesn't fit the highly specific categories like M&A (TAR) or Management Change (MANG), it falls best under the general regulatory announcement category, RNS (Regulatory Filings), as it is published pursuant to the EU Market Abuse Regulation and concerns a significant contract award.
2022-09-09 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Kvartalsrapport' (Quarterly Report) and covers the period of April-June 2022. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. Q2 2022
2022-08-25 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' and covers the period from April to June 2022. It contains detailed financial statements, including net sales, gross margins, operating profit, cash flow, and balance sheet data for both the group and the parent company. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-25 English
Ortivus receives an additional order from the Northern Ireland Ambulance Service
Regulatory Filings Classification · 95% confidence The document is a short press release announcing a new order received by Ortivus from the Northern Ireland Ambulance Service, including the value (3.2 MSEK) and expected delivery time. It contains contact information, company background, and concludes with a statement about being obliged to make the information public under the EU Market Abuse Regulation, followed by an attachment link. This structure strongly suggests a regulatory disclosure or press release announcing a specific event, rather than a comprehensive financial report (like 10-K or IR) or a management/board change (MANG). Since it is a specific, non-financial announcement that doesn't fit the other specific categories (like DIV, CAP, DIRS), the most appropriate general category for regulatory disclosures that don't fit elsewhere is Regulatory Filings (RNS). Given the short length and the nature of announcing news, it is not an Earnings Release (ER) or a Management Discussion (MDA).
2022-07-22 English
Ortivus erhåller tilläggsbeställning från Northern Ireland Ambulance Service
Earnings Release Classification · 99% confidence The document is a short press release (2780 characters) announcing a new order/contract update from a customer (Northern Ireland Ambulance Service) valued at 3.2 MSEK. It includes contact information, company background, and concludes with a statement that the information is disclosed under EU Market Abuse Regulation (MAR) and provides a link to a PDF attachment. This structure strongly suggests a regulatory disclosure of material, non-public information that doesn't fit the specific financial report categories (10-K, IR, ER). Since it is a general regulatory announcement about a business event (contract win) and not a specific financial filing, the most appropriate general category is Regulatory Filings (RNS), as it functions as a mandatory disclosure under MAR, or potentially a Capital/Financing Update (CAP) if the contract was deemed highly material to financing, but RNS is broader for general regulatory disclosures. Given the context of MAR disclosure for a business update, RNS is the best fit, although it could also be considered a general business update not covered by other specific codes. Following the rule that general regulatory announcements often fall under RNS, I select RNS. FY 2022
2022-07-22 Swedish
Ortivus is awarded a contract regarding the delivery of defibrillators to Region Västmanland
Regulatory Filings Classification · 95% confidence The document announces a specific business event: Ortivus being awarded a contract for delivering defibrillators to Region Västmanland. This is a material, non-financial announcement related to business operations and contracts. It is not a standard periodic financial report (10-K, IR, ER), a management discussion (MDA), or a shareholder vote material (DEF 14A, PSI). Since it is a specific, material announcement that doesn't fit the other specific categories (like M&A, Director's Dealing, or Capital Change), it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is explicitly stated to be information the company is obliged to make public pursuant to the EU Market Abuse Regulation (MAR). The document length is short (3987 chars) and it functions as a press release/announcement.
2022-06-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.